+1 (732) 624-9052
biz@crmedicon.com
Home
About
Company
Core Team
Advisors
Our Advantage
Jobs
Platform
Regulatory Affairs
Medical Affairs
Biopharmaceuticals
Medical Devices
Biometrics
Data Managment
Biostatistics
Statistical Programming.
Bioanalytical Lab Testing
Pharmacovigilance
Training
Solutions
China Strategy
Global Submission
Early Phase
Proof of Concept & Pivotal
Medical Device
Bioequivalence
Resources
News
News & Updates
Events
Q&A
Contact
中文
News & Updates
Filter by
Categories
Tags
Authors
Show all
All
China Market
CR Medicon Updates
CRO
Events
NMPA
Pharmacovigilance
Q&A
Regulatory
Uncategorized
All
clinical development
clinical trial
medidata
platform
All
Charles Li
Chere Zhou
crmedicon@fanzappy.com
leew@fanzappy.com
Mudit Verma
Xiaodong Wang
Xingyan Dou
November 18, 2019
November 18, 2019
Categories
Uncategorized
CR Medicon Expands Pharmacovigilance Management Capability in China With Oracle Argus
Nanjing, China Nov. 12, 2019 Nanjing CR Medicon Pharmaceutical Technology CO., Ltd., a Gold level member of Oracle
[…]
April 13, 2021
April 13, 2021
Categories
China Market
CRO
Why Conduct Clinical Trials in China? A Patient Recruitment Perspective
China-based pharmaceutical companies have experienced noteworthy success in achieving patient recruitment milestones, even in the
[…]
April 2, 2021
April 2, 2021
Categories
China Market
Regulatory
Why Conduct Clinical Trials in China? A Regulatory Perspective
The ongoing pandemic has changed the landscape of clinical development in prominent ways. Conducting clinical
[…]
November 19, 2020
November 19, 2020
Categories
Uncategorized
Predicine and CR Medicon form strategic partnership to accelerate global Clinical Trials and Registration Approval
On November 11, 2020, CR Medicon and Predicine jointly announced that it has entered into
[…]
April 6, 2020
April 6, 2020
Categories
Uncategorized
Webinar: China NMPA and US FDA Emergency Approval and Implications to Life Science Companies Relating to COVID-19
Time: Tue, 07 April 2020 11:00 AM – 12:30 PM (EST) As COVID-19 has become
[…]
December 26, 2019
December 26, 2019
Categories
NMPA
Pharmacovigilance
China Annual ADR & ADE Monitoring Report (2018)
NMPA released an annual report on ADR & ADE monitoring in China (the 2018 version).
[…]
December 25, 2019
December 25, 2019
Categories
Regulatory
US-China Clinical Trial Regulatory Overview
In this publication, we give a side-by-side comparative overview of clinical trial regulatory commonalities and
[…]
December 21, 2019
December 21, 2019
Categories
China Market
CRO
Innovative Chemical Drug Development in China
Compared with generic drugs, the development of innovative chemical drugs is more difficult, expensive, and
[…]
December 21, 2019
December 21, 2019
Categories
CRO
CRO in China – Leading the World with Rapid Growth
In recent years, the CRO (Contract Research Organization) industry in China has entered a “golden
[…]
1
2
Next page
中文